InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Finn Jonathan, Director. Officer active across 1 companies, notably Atossa Therapeutics, INC.. In total, 2 disclosures have been published. The latest transaction was filed on 12 May 2026 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
010,000 shares0
Common Stock
SEC:0001193125-26-224135·
010,000 shares0
Common Stock
SEC:0001193125-26-224135:0·
2 of 2 declarations
About Finn Jonathan
Jonathan Finn is a Director at Atossa Therapeutics, Inc. As a board member, he participates in the governance of the company and strategic decision-making. His experience in the biotechnology sector allows him to provide valuable insights into growth and innovation opportunities. He plays a key role in the future direction of the company.
